Second primary malignant neoplasms: A clinicopathological analysis from a cancer centre in india

Narendra Hulikal, Satadru Ray, Joseph Thomas, Donald J. Fernandes

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Context: Patients diagnosed with a cancer have a life time risk of developing another de novo malignancy depending on various inherited, environmental and iatrogenic risk factors. Of late the detection of new primary has increased mainly due to refinement in both diagnostic and treatment modalities. Cancer victims are surviving longer and thus are more likely to develop a new metachronous malignancy. Aims: To report our observed trend of increase in prevalence of both synchronous and metachronous second malignant neoplasms among cancer victims and to review the relevant literature. Settings and Design: A hospital based retrospective collection of prospective data of patients diagnosed with second denovo malignancy. Materials and Method: The study was conducted over a 5 year period from July 2008 to June 2012. All patients diagnosed with a histologically proven second malignancy as per Warren Gate's criteria were included. Various details regarding sex, age at presentation, synchronous or metachronous, treatment and outcome were recorded. Conclusions: The occurrence of multiple primary malignancies is not rare. Awareness of the possibility alerts the clinician in evaluation of patients with a known malignancy presenting with unusual sites of metastasis. Individualizing the treatment according to the stages of the primaries will result in durable cancer control ol particularly in synchronous double malignancy.

Original languageEnglish
Pages (from-to)6087-6091
Number of pages5
JournalAsian Pacific Journal of Cancer Prevention
Volume13
Issue number12
DOIs
Publication statusPublished - 01-01-2012

Fingerprint

Second Primary Neoplasms
India
Neoplasms
Hospital Design and Construction
Neoplasm Metastasis

All Science Journal Classification (ASJC) codes

  • Epidemiology
  • Oncology
  • Public Health, Environmental and Occupational Health
  • Cancer Research

Cite this

Hulikal, Narendra ; Ray, Satadru ; Thomas, Joseph ; Fernandes, Donald J. / Second primary malignant neoplasms : A clinicopathological analysis from a cancer centre in india. In: Asian Pacific Journal of Cancer Prevention. 2012 ; Vol. 13, No. 12. pp. 6087-6091.
@article{c1b667e7d1ff43a0bfddd1e8728083e7,
title = "Second primary malignant neoplasms: A clinicopathological analysis from a cancer centre in india",
abstract = "Context: Patients diagnosed with a cancer have a life time risk of developing another de novo malignancy depending on various inherited, environmental and iatrogenic risk factors. Of late the detection of new primary has increased mainly due to refinement in both diagnostic and treatment modalities. Cancer victims are surviving longer and thus are more likely to develop a new metachronous malignancy. Aims: To report our observed trend of increase in prevalence of both synchronous and metachronous second malignant neoplasms among cancer victims and to review the relevant literature. Settings and Design: A hospital based retrospective collection of prospective data of patients diagnosed with second denovo malignancy. Materials and Method: The study was conducted over a 5 year period from July 2008 to June 2012. All patients diagnosed with a histologically proven second malignancy as per Warren Gate's criteria were included. Various details regarding sex, age at presentation, synchronous or metachronous, treatment and outcome were recorded. Conclusions: The occurrence of multiple primary malignancies is not rare. Awareness of the possibility alerts the clinician in evaluation of patients with a known malignancy presenting with unusual sites of metastasis. Individualizing the treatment according to the stages of the primaries will result in durable cancer control ol particularly in synchronous double malignancy.",
author = "Narendra Hulikal and Satadru Ray and Joseph Thomas and Fernandes, {Donald J.}",
year = "2012",
month = "1",
day = "1",
doi = "10.7314/APJCP.2012.13.12.6087",
language = "English",
volume = "13",
pages = "6087--6091",
journal = "Asian Pacific Journal of Cancer Prevention",
issn = "1513-7368",
publisher = "Asian Pacific Organization for Cancer Prevention",
number = "12",

}

Second primary malignant neoplasms : A clinicopathological analysis from a cancer centre in india. / Hulikal, Narendra; Ray, Satadru; Thomas, Joseph; Fernandes, Donald J.

In: Asian Pacific Journal of Cancer Prevention, Vol. 13, No. 12, 01.01.2012, p. 6087-6091.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Second primary malignant neoplasms

T2 - A clinicopathological analysis from a cancer centre in india

AU - Hulikal, Narendra

AU - Ray, Satadru

AU - Thomas, Joseph

AU - Fernandes, Donald J.

PY - 2012/1/1

Y1 - 2012/1/1

N2 - Context: Patients diagnosed with a cancer have a life time risk of developing another de novo malignancy depending on various inherited, environmental and iatrogenic risk factors. Of late the detection of new primary has increased mainly due to refinement in both diagnostic and treatment modalities. Cancer victims are surviving longer and thus are more likely to develop a new metachronous malignancy. Aims: To report our observed trend of increase in prevalence of both synchronous and metachronous second malignant neoplasms among cancer victims and to review the relevant literature. Settings and Design: A hospital based retrospective collection of prospective data of patients diagnosed with second denovo malignancy. Materials and Method: The study was conducted over a 5 year period from July 2008 to June 2012. All patients diagnosed with a histologically proven second malignancy as per Warren Gate's criteria were included. Various details regarding sex, age at presentation, synchronous or metachronous, treatment and outcome were recorded. Conclusions: The occurrence of multiple primary malignancies is not rare. Awareness of the possibility alerts the clinician in evaluation of patients with a known malignancy presenting with unusual sites of metastasis. Individualizing the treatment according to the stages of the primaries will result in durable cancer control ol particularly in synchronous double malignancy.

AB - Context: Patients diagnosed with a cancer have a life time risk of developing another de novo malignancy depending on various inherited, environmental and iatrogenic risk factors. Of late the detection of new primary has increased mainly due to refinement in both diagnostic and treatment modalities. Cancer victims are surviving longer and thus are more likely to develop a new metachronous malignancy. Aims: To report our observed trend of increase in prevalence of both synchronous and metachronous second malignant neoplasms among cancer victims and to review the relevant literature. Settings and Design: A hospital based retrospective collection of prospective data of patients diagnosed with second denovo malignancy. Materials and Method: The study was conducted over a 5 year period from July 2008 to June 2012. All patients diagnosed with a histologically proven second malignancy as per Warren Gate's criteria were included. Various details regarding sex, age at presentation, synchronous or metachronous, treatment and outcome were recorded. Conclusions: The occurrence of multiple primary malignancies is not rare. Awareness of the possibility alerts the clinician in evaluation of patients with a known malignancy presenting with unusual sites of metastasis. Individualizing the treatment according to the stages of the primaries will result in durable cancer control ol particularly in synchronous double malignancy.

UR - http://www.scopus.com/inward/record.url?scp=84877014799&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84877014799&partnerID=8YFLogxK

U2 - 10.7314/APJCP.2012.13.12.6087

DO - 10.7314/APJCP.2012.13.12.6087

M3 - Article

C2 - 23464409

AN - SCOPUS:84877014799

VL - 13

SP - 6087

EP - 6091

JO - Asian Pacific Journal of Cancer Prevention

JF - Asian Pacific Journal of Cancer Prevention

SN - 1513-7368

IS - 12

ER -